A61K 38/2235
Secretins
Official title: {Secretins}
A61K38/2235 (Secretins) appears on 67 US grants and 99 published applications in this corpus.
Search patents in A61K- Granted patents
- 67
- Published applications
- 99
- Assignees
- 41
- Inventors
- 136
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 5 |
| 2003 | 4 | 0 |
| 2004 | 3 | 6 |
| 2005 | 1 | 6 |
| 2006 | 2 | 4 |
| 2007 | 1 | 3 |
| 2008 | 1 | 1 |
| 2009 | 0 | 4 |
| 2010 | 0 | 5 |
| 2011 | 4 | 4 |
| 2012 | 3 | 8 |
| 2013 | 6 | 2 |
| 2014 | 6 | 5 |
| 2015 | 0 | 2 |
| 2016 | 3 | 2 |
| 2017 | 4 | 3 |
| 2018 | 2 | 3 |
| 2019 | 3 | 7 |
| 2020 | 4 | 4 |
| 2021 | 1 | 4 |
| 2022 | 5 | 5 |
| 2023 | 2 | 5 |
| 2024 | 1 | 4 |
| 2025 | 2 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method to induce exfoliation of cells and/or tissue fragments for enhanced cytopathologic cell collection16 Jun 2026US 12,653,509 B2Adenocyte Ltd.
- Long-acting amylin receptor agonists and uses thereof17 Feb 2026US 12,551,532 B2Eli Lilly and Company
- Compositions and methods for treating obesity and hyperphagia30 Dec 2025US 12,508,299 B2Metrohealth Ventures LLC
- Swallowable drug delivery device and methods of drug delivery8 Apr 2025US 12,268,831 B2Rani Therapeutics, LLC
- Long acting amylin receptor agonists and uses thereof15 Oct 2024US 12,115,210 B2Eli Lilly and Company
- Method to induce exfoliation of cells and/or tissue fragments for enhanced cytopathologic cell collection8 Oct 2026US 2026/0306077 A1Adenocyte Ltd.
- Exogenous protein-expressing microorganism and use thereof8 Oct 2026US 2026/0306586 A1Medytox Inc.
- Preserved gip/glp agonist compositions14 May 2026US 2026/0130970 A1Eli Lilly and Company
- Tirzepatide compositions and preparation method4 Dec 2025US 2025/0367260 A1
- Glp-1/gip dual-targeted polypeptide and fusion protein and applications thereof10 Jul 2025US 2025/0223331 A1Sunshine Lake Pharma Co., Ltd.
Most cited
By later US patents
- Swallowable drug delivery device and methods of drug delivery154US 8,721,620 B2Rani Therapeutics, LLC · 2014
- Swallowable drug delivery device and method of delivery119US 8,562,589 B2Rani Therapeutics, LLC · 2013
- Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device116US 8,759,284 B2Rani Therapeutics, LLC · 2014
- Swallowable drug delivery device and method of delivery84US 8,852,151 B2Rani Therapeutics, LLC · 2014
- Method for assisting in differential diagnosis and treatment of autistic syndromes82US 6,020,310 ARepligen Corporation · 2000